ARADIGM CORPORATION

Company Information
Address 3929 POINT EDEN WAY
HAYWARD, CA, 94545-3720

http://www.aradigm.com/

Information

DUNS: 792998783

# of Employees: 21


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus

    Amount: $486,599.00

    Project Summary Lung infections by non tuberculous mycobacteria NTM Mycobacterium avium and Mycobacterium abscessus are increasing in incidence Diseases caused by both Mycobacteria are common in pa ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Evaluation of a new class of molecules for treating MRSA infective endocarditis

    Amount: $277,768.00

    DESCRIPTION (provided by applicant): Lung infections by Mycobacterium avium and Mycobacterium abscessus are increasing in incidence. Diseases caused by both Mycobacteria are common in patients with ch ...

    SBIRPhase I2013Department of Health and Human Services
  3. Amplified Attention Training (AAT) for the Treatment of Hemispatial Nelgect

    Amount: $339,824.00

    DESCRIPTION (provided by applicant): Although recurrent microaspiration of refluxed gastric fluid ( GER with microaspiration ) is suspected in the onset and course of many diseases of the lungs and ai ...

    SBIRPhase I2013Department of Health and Human Services
  4. Pulmonary delivery of nicotine using the AERx System

    Amount: $153,151.00

    DESCRIPTION (provided by applicant): Each year more Americans die from smoking-related diseases than from alcohol, AIDS, drug abuse, car accidents, fire, suicide and murder-combined. Smoking costs the ...

    SBIRPhase I2005Department of Health and Human Services
  5. Developing Human-Compatible Needleless Delivery Systems for Administering Bioscavengers

    Amount: $70,000.00

    The goals of this proposal are: 1) to identify a BChE formulation that will deliver the target systemic dose via the lungs; 2) to ensure that the integrity of the BChE protein is unaffected by the aer ...

    SBIRPhase I2003Army Department of Defense
  6. PULMONARY GENE TRANSFER DELIVERY SYSTEMS

    Amount: $750,000.00

    DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, ...

    SBIRPhase II1998Department of Health and Human Services
  7. PULMONARY GENE TRANSFER DELIVERY SYSTEMS

    Amount: $99,750.00

    DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, ...

    SBIRPhase I1997Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government